Q4 2025 · 13F-HR
PFIZER INC (PFE)holdings as filed
Filed 2026-02-12 · accession 0000078003-26-000013
$236.5M
Reported value
18
Positions
2025-12-31
Period end
The Brief · PFIZER INC (PFE) · Q4 2025
AI · grounded in 13F
PFIZER INC (PFE) closed its position in BIONTECH SE BNTX, reducing its holdings by $163.5M. The fund also exited its position in TOURMALINE BIO INC TRML for $60.8M and closed its stake in ESSA PHARMA INC EPIEUR valued at $319,925. Additionally, the fund trimmed its position in SENSEONICS HLDGS INC SENS1GBP by 95%.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $44.0M | 18.6% | 5,376,344 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $41.0M | 17.3% | 3,457,815 | Common | SOLE |
| 15102K100 | CELC | CELCUITY INC | $34.8M | 14.7% | 349,406 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $31.9M | 13.5% | 1,875,000 | Common | SHARED |
| 019770106 | ALLO | ALLOGENE THERAPEUTICS INC | $30.2M | 12.8% | 22,032,040 | Common | SOLE |
| G9TY5A101 | ZURA | ZURA BIO LTD | $15.6M | 6.58% | 2,970,022 | Common | SOLE |
| 747324101 | PYXS | PYXIS ONCOLOGY INC | $8.1M | 3.42% | 7,032,770 | Common | SOLE |
| 142038108 | CRBU | CARIBOU BIOSCIENCES INC | $7.5M | 3.15% | 4,690,431 | Common | SOLE |
| 14147L108 | CRDF | CARDIFF ONCOLOGY INC | $6.8M | 2.87% | 2,411,575 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $5.7M | 2.41% | 505,645 | Common | SOLE |
| 84833T103 | SPRO | SPERO THERAPEUTICS INC | $5.5M | 2.33% | 2,362,348 | Common | SOLE |
| 65343E207 | NXTC | NEXTCURE INC | $2.2M | 0.95% | 157,646 | Common | SOLE |
| 98943L107 | ZNTL | ZENTALIS PHARMACEUTICALS INC | $1.3M | 0.54% | 953,834 | Common | SOLE |
| 746964105 | QTTB | Q32 BIO INC | $922,220 | 0.39% | 277,777 | Common | SOLE |
| 037326105 | ANTX | AN2 THERAPEUTICS INC | $815,436 | 0.34% | 715,295 | Common | SHARED |
| 097702203 | BOLT | BOLT BIOTHERAPEUTICS INC | $171,176 | 0.07% | 31,305 | Common | SHARED |
| 37611X209 | DNA | GINKGO BIOWORKS HOLDINGS INC | $24,332 | 0.01% | 2,928 | Common | SOLE |
| 81727U105 | SENS1GBP | SENSEONICS HLDGS INC | $11,983 | 0.01% | 2,171 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.